Ovctek China (SZSE:300595) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ovctek China Additional Paid-In Capital?

Ovctek China's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥1,155 Mil) but then stayed the same from Dec. 2023 (¥1,155 Mil) to Mar. 2024 (¥0 Mil).

Ovctek China's annual additional paid-in capital increased from Dec. 2021 (¥28 Mil) to Dec. 2022 (¥1,525 Mil) but then declined from Dec. 2022 (¥1,525 Mil) to Dec. 2023 (¥1,155 Mil).

Ovctek China Additional Paid-In Capital Historical Data

The historical data trend for Ovctek China's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovctek China Additional Paid-In Capital Chart

Ovctek China Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

210.87

46.63

28.24

1,524.91

1,154.89

Ovctek China Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	1,528.83	-	1,154.89	-

Ovctek China Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Ovctek China Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Ovctek China's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovctek China (SZSE:300595) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ovctek China Inc (SZSE:300595) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 4899 Wangjiang West Road, High-tech Zone, Anhui Province, Hefei, CHN, 230088

Website

http://www.orthok.cn

Ovctek China Inc is a China-based company engaged in the research and development, production, and sales of rigid gas permeable contact lens products. Its products include Hard Mirror, Mirror Teshu family, High-end ophthalmic products, and Security products. The company-owned trademarks are DreamVision, DreamDawei, Ri Dawei, Hua Cone, Jing Teshu, openvision, and Mengshiqing among others.

Executives

Tao Yue Qun	Directors, executives
	Directors, executives
Yin Yin	Director

Ovctek China (SZSE:300595) Headlines

No Headlines